Clinical trials
Myositis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 10 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 20 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 4 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 8 |
| National Institute of Environmental Health Sciences (NIEHS) | 6 |
| Novartis Pharmaceuticals | 4 |
| Johns Hopkins University | 3 |
| argenx | 3 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
| Fate Therapeutics | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| Kezar Life Sciences, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 78 |
| Dermatomyositis | 35 |
| Polymyositis | 26 |
| Lupus Erythematosus, Systemic | 16 |
| Arthritis, Rheumatoid | 15 |
| Myositis, Inclusion Body | 15 |
| Scleroderma, Systemic | 15 |
| Autoimmune Diseases | 14 |
| Scleroderma, Diffuse | 14 |
| Muscular Diseases | 12 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.